Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: Possible relation to oxidative stress

Journal of the Neurological Sciences

Volumn 143, Issue 1-2, 1996, Pages 137-142

  Deibel, M A ^a   Ehmann, W D ^a,b   Markesbery, W R ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; Brain; Copper; Iron; Oxidative stress; Zinc

Indexed keywords

COPPER; IRON; ZINC;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN INJURY; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYGDALA; CEREBELLUM; COPPER; DATA INTERPRETATION, STATISTICAL; FEMALE; HIPPOCAMPUS; HUMANS; IRON; MALE; METALS, HEAVY; NERVE DEGENERATION; OXIDATIVE STRESS; PARIETAL LOBE; TEMPORAL LOBE; ZINC;

EID: 0030297178     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(96)00203-1     Document Type: Article

References (47)

1. Burnet F.M. A possible role of zinc in the pathology of dementia. Lancet. 1:1981;186-188.
2. Bush A.I., Pettingell W.H., Multhaup G., Paradis M.D., Vonsattel J.-P., Gusella J.F., Beyreuther K., Masters C.L., Tanzi R.E. Rapid induction of Alzheimer A β amyloid formation by zinc. Science. 265:1994;1464-1467.
3. Butterfield DA, Hensley K., Harris M., Mattson, Carney JM β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200:1994;710-715.
4. Chandrasekaran K., Giordano T., Brady D.R., Stoll J., Martin L.J., Rapoport S.I. Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease. Mol Brain Res. 24:1994;336-340.
5. Connor J.R., Tucker P., Johnson M., Snyder B. Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease. Neurosci Lett. 159:1993;88-90.
6. Coyle JT, Puttfarcken P. Oxidative stress, glutamate and neurodegenerative disorders. Science. 262:1993;689-695.
7. De Lustig E.S., Serra J.A., Kohan S., Canziani G.A., Famulari A.L., Dominguez R.O. Copper-zinc superoxide dismutase activity in red blood cells and serum in demented patients and in aging. J. Neurological. Sci. 115:1993;18-25.
8. De Silva D.M., Aust S.D. Ferritin and ceruloplasmin in oxidative damage: review and recent findings. Can. J. Physiol. Pharmacol. 71:1993;715-720.
9. Deibel, M.A., Landsberger, S., Wu, D., Ehmann, W.D. (1996) Non-destructive analysis of copper in human brain tissue by neutron activation analysis using coincidence and anti-coincidence techniques. (submitted).
10. Ehmann W.D., Markesbery W.R., Alauddin M., Hossain T.I.M., Brubaker E.H. Brain trace elements in Alzheimer's disease. Neurotoxicology. 7:1986;197-206.
11. Ehmann W.D., Markesbery W.R., Kasarskis E.J., Vance D.E., Khare S.S., Hord J.D., Thompson C.M. Application of neutron activation analysis to the study of age-related neurological diseases. Biol. Trace Elem. Res. 13:1987;19-33.
12. Fleming J., Joshi J.G. Ferritin: isolation of aluminum-ferritin complex from brain. Proc. Natl. Acad. Sci. USA. 84:1987;7866-7870.
13. Good P.F., Perl D.P., Bierer L.M., Schmeidler J. Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann. Neurol. 31:1992;286-292.
14. Goodman L. Alzheimer's disease: a clinico-pathologic analysis of twenty-three cases with a theory on pathogenesis. J. Nerv. Ment. Dis. 117:1953;97-130.
15. Grundke-Iqbal I., Fleming J., Tung Y.C., Lassman H., Iqbal K., Joshi J.G. Ferritin is a component of neuritic (senile) plaque in Alzheimer dementia. Acta Neuropathol. 81:1990;105-110.
16. Gutteridge J.M.C., Quinlan G.J. Antioxidant protection against organic and inorganic oxygen radicals by normal human plasma: the important primary role for iron-binding and iron-oxidising proteins. Biochimica. et Biophysica. Acta. 1156:1993;144-150.
17. Hensley K., Carney JM., Mattson MPet al. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 91:1994;3270-3274.
18. Katzman R. The prevalence and malignancy of Alzheimer's disease: a major killer. Arch. Neurol. 33:1976;217-218.
19. Kawamata T., Tooyama I., Yamada T., Walker D.G., McGeer P.L. Lactotransferrin immunocytochemistry in Alzheimer and normal human brain. Am. J. Pathol. 142:1993;1574-1585.
20. Khachaturian Z.S. Diagnosis of Alzheimer's disease. Arch. Neurol. 42:1985;1097-1105.
21. Kish S.J., Bergeron C., Rajput A., Dozic S., Mastrogiacomo F., Chang L-J., Wilson J.M., DiStefano L.M., Nobrega J.N. Brain cytochrome oxidase in Alzheimer's disease. J. Neurochem. 59(2):1992;776-779.
22. Krsek-Staples J.A., Webster R.O. Ceruloplasmin inhibits carbonyl formation in endogenous cell proteins. Free Radic. Biol. Med. 14:1993;115-125.
23. Ledesma MD, Bonay P, Colaco C, Avila J Analyses of microtubule-associated protein tau glycation in paired helical filaments. J. Biol. Chem. 269:1994;21614-21619.
24. Lovell M.A., Ehmann W.D., Butler S.M., Markesbery W.R. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology. 45:1995;1594-1601.
25. Markesbery W.R., Ehmann W.D., Hossain T.I.M., Alauddin M., Goodin D.T. Instrumental neutron activation analysis of brain aluminum in Alzheimer's disease and aging. Ann. Neurol. 10:1981;511-516.
26. McKhann G.D., Drachman D.A., Folstein M.F., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA Work Group Under the Auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
27. Mecocci P, MacGarvey U, Beal MF Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36:1994;747-751.
28. Mirra S.S., Heyman A., McKeel D.et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 41:1991;479-486.
29. Mortimer, J.A., Hutton, J.T. (1985) Epidemiology and etiology of Alzheimer's disease. In Hutton, J.T., Kenny, A.D. (Eds.) Senile Dementia of the Alzheimer Type. Liss, New York, pp. 177-196.
30. Multhaup G., Schlicksupp A., Hesse L., Beher D., Ruppert T., Masters C.L., Beyreuther K. The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I). Science. 271:1996;1406-1409.
31. Mutisya E.M., Bowling A.C., Beal M.F. Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J. Neurochem. 63:1994;2179-2184.
32. Nadkarni R.A., Ehmann W.D. Determination of trace elements in biological standard Kale by neutron activation analysis. J. Radioanal. Chem. 3:1969;175-185.
33. Olanow C.W. A radical hypothesis for neurodegeneration. Trends Neurosci. 16:1993;439-444.
34. Petra M., Swift G., Landsberger S. Design of a Ge-NaI(Tl) Compton suppression spectrometer and its use in neutron activation analysis. Nucl. Instrum. Methods Phys. Res. A299:1990;85-87.
35. Plantin L-O, Lysing-Tunell U., Kristensson K. Trace elements in the human central nervous system studied with neutron activation analysis. Biol. Trace Element Res. 13:1987;69-75.
36. Reichmann H., Flörke S., Hebenstreit G., Schrubar H., Riederer P. Analyses of energy metabolism and mitochondrial genome in postmortem brain from patients with Alzheimer's disease. J. Neurol. 240:1993;377-380.
37. Samokyszyn V.M., Reif D.W., Miller D.M., Aust S.D. Effects of ceruloplasmin on superoxide dependent iron release from ferritin and lipid peroxidation. Free. Radic. Res. Comms. 12-13:1991;153-159.
38. Samudralwar D.L., Diprete C.C., Ni B.-F., Ehmann W.D., Markesbery W.R. Elemental imbalances in the olfactory pathway in Alzheimer's disease. J. Neurol. Sci. 130:1995;139-145.
39. Serra J.A., Famulari A.L., Kohan S., Marschoff E.R., Dominguez R.O., de Lustig E.S. Copper-zinc superoxide dismutase activity in red blood cells in probable Alzheimer's patients and their first-degree relatives. J. Neurol. Sci. 122:1994;179-188.
40. Simonian N.A., Hyman B.T. Functional alterations in Alzheimer's disease: Diminution of cytochrome oxidase in the hippocampal formation. J. Neuropathol. Exp. Neurol. 52:1993;580-585.
41. Smith C.D., Carney J.M., Starke-Reed P.E., Oliver C.N., Stadtman E.R., Floyd R.A., Markesbery W.R. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc. Natl. Acad. Sci., USA. 81:1991;10540-110543.
42. Switzer, R.C., Martin, T.L., Campbell, S.K., Parker, J.C., Caldwell, E.D. (1986) Iron and ferritin in the neuritic plaques of Alzheimer's disease. Soc. Neurosci. Abstr., 100.
43. Tandon L., Ni B-F, Ding X.X., Ehmann W.D., Kasarskis E.J., Markesbery W.R. RNAA for arsenic, cadmium, copper, and molybdenum in CNS tissues from subjects with age-related neurodegenerative diseases. J. Radional. Nucl. Chem. 179:1994;331.
44. Thompson C.M., Markesbery W.R., Ehmann W.D., Mao Y.X., Vance D.E. Regional brain trace-element studies in Alzheimer's disease. Neurotoxicology. 9:1988;1-8.
45. Vitek MP, Bhattacharya K, Glendening JMet al. Advanced glycation end products contribute to amyloidosis in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 91:1994;4766-4770.
46. Ward N.I., Mason J.A. Neutron activation analysis for identifying elemental status in Alzheimer's disease. J. Radioanal. Nucl. Chem. 113:1987;515-526.
47. Yan SD, Chen X, Schmidt A-Met al. Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc. Natl. Acad. Sci. USA. 91:1994;7787-7791.